- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Onelife Capital Advisors (ONELIFECAP) reported a challenging quarter.
1) **Revenue Performance:** Consolidated revenue from operations plunged 88.25% year-over-year to ₹0.85 Cr from ₹7.21 Cr. This sharp decline was primarily driven by a 90.25% fall in Broking Services revenue and no revenue from Trading Services, which previously contributed ₹3.65 Cr. Other income, however, saw an increase.
2) **Profitability and EPS:** The company swung to a net loss of ₹0.53 Cr for the quarter, compared to a net profit of ₹0.65 Cr in the prior year. Basic and Diluted EPS also turned negative at (₹0.39) from ₹0.49.
3) **Operational Costs:** Total expenses decreased to ₹2.42 Cr from ₹6.90 Cr, with reductions in employee benefits, finance costs, and other expenses. Despite cost controls, the massive revenue drop led to unprofitability.
5) **Balance Sheet / Cash Flow Health:** While the company reported zero outstanding debt, a significant concern highlighted by auditors is the non-realization of a ₹25 Cr cheque for a subsidiary's investment sale to the holding company. Only a very small portion of this amount was realized before the original cheque expired, and a new cheque for the balance has been received. This indicates potential liquidity challenges until fully cleared. Auditors also noted investments worth ₹87.22 Cr in subsidiaries with negative net worth.
6) **Strategic Outlook:** The company faces an ongoing SEBI order directing a payment of ₹0.50 Cr (per company & directors) for alleged non-compliances, with an appeal filed and a 50% pre-deposit directed by SAT. The financial impact remains uncertain. The auditor's concern over the uncashed cheque points to a need for urgent cash flow management.
7) **Final Takeaway:** The latest results signal weak momentum. The steep revenue decline, coupled with significant concerns around cash realization from asset sales and unresolved regulatory matters, presents a high-risk profile for retail investors.